Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Menarini Biotech is the specialized biotechnology division of the Menarini Group, focusing on the development and manufacturing of biologics. Operating as a Contract Development and Manufacturing Organization (CDMO), the company provides end-to-end services including cell line development, process development, and GMP-compliant manufacturing of monoclonal antibodies and recombinant proteins. With advanced facilities located in Italy, Menarini Biotech supports both the internal pipeline of the Menarini Group and external pharmaceutical partners from early-stage clinical trials through to commercial production. The company leverages its deep expertise in protein engineering and large-scale bioprocessing to deliver high-quality therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Menarini Biotech.